National Association of Chain Drug Stores (NACDS) President and CEO Steven C. Anderson issued a statement today following House passage of appropriations legislation that includes critical pharmacy benefit manager (PBM) reforms for which NACDS has long advocated. The legislation, which passed the House with a 217-214 vote and previously passed the Senate with a 71-29 vote, now proceeds to President Trump’s desk for his signature.

Anderson stated:

“Congress and the Trump Administration are delivering a historic win for the American people and for the trusted pharmacies that serve as the face of neighborhood healthcare. These PBM reforms are integral to reducing people’s drug costs and keeping pharmacy care within reach, and they must be implemented swiftly, effectively, and as intended by Congress.

“The abuses of the dominant PBM middlemen are widely recognized, and this landmark federal action reflects the broad, bipartisan commitment to confront and remedy them. This is the most important federal achievement yet for PBM reform, and it will sustain and build momentum for further reforms where needed.

“We are deeply grateful to the bipartisan champions who crafted and advanced these reforms, to the members of Congress who cast decisive votes, and to President Trump for his commitment to rein in middlemen practices that have harmed patients and undermined pharmacy access.”

RELATED CONTENT:

NACDS Applauds Senate Passage

NACDS Praises House Passage

NACDS Key-Votes Bill

Pharmacy Coalition Statement

Pharmacy Coalition Letter

NACDS Ads

Pharmacy Closures: Polling and Video

NACDS Letter to Congressional Leadership

Share this story:

Related Posts

  • Pharmacy Coalition Commends CMS RFI on Medicare Part D Reasonable and Relevant Pharmacy Contracting Standards

  • In Case You Missed It: NACDS Policy Council Members Make Push for Main Street Pharmacy Access Act on Capitol Hill

  • NACDS to Senate Armed Services Subcommittee: Strengthen the TRICARE Pharmacy Program Through Access, Choice, Transparency, and Accountability

    NACDS urges Congress to preserve TRICARE pharmacy oversight provisions in the Fiscal Year 2027 NDAA.